Skip to main content
Erschienen in: Journal of Thrombosis and Thrombolysis 2/2021

24.06.2020

Characteristics of aged ischemic stroke patients indicative of cardioembolism

verfasst von: Kosuke Matsuzono, Takafumi Mashiko, Tadashi Ozawa, Kumiko Miura, Masayuki Suzuki, Kohei Furuya, Misato Ozawa, Yuhei Anan, Haruo Shimazaki, Reiji Koide, Ryota Tanaka, Tomoaki Kameda, Shigeru Fujimoto

Erschienen in: Journal of Thrombosis and Thrombolysis | Ausgabe 2/2021

Einloggen, um Zugang zu erhalten

Abstract

The treatment of ischemic stroke has recently witnessed dramatic developments. However, there are limited data on ischemic stroke characteristics in aged patients. As part of the South Tochigi Acute Ischemic Stroke Registry, we prospectively enrolled 636 consecutive acute ischemic stroke patients (within 7 days after the onset) who were ≥ 60 years of age and who were admitted to two independent institutes from April 1, 2016 to February 28, 2019. We analyzed three groups divided by age: early-aged (60–69 years), middle-aged (70–79 years), and oldest-aged (≥ 80 years). From the 636 subjects, 194 were early-aged, 215 were middle-aged, and 227 were oldest-aged. There were significant differences in the ischemic stroke subtypes in each aging group (p < 0.01). The proportion of cardioembolism was 22.2% in early-aged, 27.4% in middle-aged, and 41.4% in the oldest-aged patients. The proportion of patients with a modified Rankin Scale of 0–2 at 1 year after onset decreased to 42.2% in middle-aged and 17.8% in oldest-aged with cardioembolic ischemic stroke. The proportion of patients receiving anticoagulation therapy before admission was 25.6% (36.7% of atrial fibrillation [AF]) in early-aged, 39.0% (52.3% of AF) in middle-aged, and 18.1% (21.0% of AF) in oldest-aged patients (p < 0.001). Our study reports characteristics of clinical ischemic stroke in an aging population. The assessment of cardiogenic embolism is important for an aging population.
Literatur
1.
Zurück zum Zitat National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group (1995) Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333(24):1581–1587CrossRef National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group (1995) Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333(24):1581–1587CrossRef
2.
Zurück zum Zitat Hacke W, Kaste M, Bluhmki E et al (2008) Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 359(13):1317–1329CrossRef Hacke W, Kaste M, Bluhmki E et al (2008) Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 359(13):1317–1329CrossRef
3.
Zurück zum Zitat Berkhemer OA, Fransen PS, Beumer D et al (2015) A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med 372(1):11–20CrossRef Berkhemer OA, Fransen PS, Beumer D et al (2015) A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med 372(1):11–20CrossRef
4.
Zurück zum Zitat Goyal M, Demchuk AM, Menon BK et al (2015) Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med 372(11):1019–1030CrossRef Goyal M, Demchuk AM, Menon BK et al (2015) Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med 372(11):1019–1030CrossRef
5.
Zurück zum Zitat Campbell BC, Mitchell PJ, Kleinig TJ et al (2015) Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med 372(11):1009–1018CrossRef Campbell BC, Mitchell PJ, Kleinig TJ et al (2015) Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med 372(11):1009–1018CrossRef
6.
Zurück zum Zitat Saver JL, Goyal M, Bonafe A et al (2015) Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med 372(24):2285–2295CrossRef Saver JL, Goyal M, Bonafe A et al (2015) Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med 372(24):2285–2295CrossRef
7.
Zurück zum Zitat Connolly SJ, Ezekowitz MD, Yusuf S et al (2009) Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 361(12):1139–1151CrossRef Connolly SJ, Ezekowitz MD, Yusuf S et al (2009) Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 361(12):1139–1151CrossRef
8.
Zurück zum Zitat Patel MR, Mahaffey KW, Garg J et al (2011) Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med 365(10):883–891CrossRef Patel MR, Mahaffey KW, Garg J et al (2011) Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med 365(10):883–891CrossRef
9.
Zurück zum Zitat Granger CB, Alexander JH, McMurray JJ et al (2011) Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 365(11):981–992CrossRef Granger CB, Alexander JH, McMurray JJ et al (2011) Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 365(11):981–992CrossRef
10.
Zurück zum Zitat Giugliano RP, Ruff CT, Braunwald E et al (2013) Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med 369(22):2093–2104CrossRef Giugliano RP, Ruff CT, Braunwald E et al (2013) Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med 369(22):2093–2104CrossRef
11.
Zurück zum Zitat Yoshitake T, Kiyohara Y, Kato I et al (1995) Incidence and risk factors of vascular dementia and Alzheimer’s disease in a defined elderly Japanese population: the Hisayama study. Neurology 45(6):1161–1168CrossRef Yoshitake T, Kiyohara Y, Kato I et al (1995) Incidence and risk factors of vascular dementia and Alzheimer’s disease in a defined elderly Japanese population: the Hisayama study. Neurology 45(6):1161–1168CrossRef
12.
Zurück zum Zitat Kato Y, Hayashi T, Tanahashi N, Kobayashi S, Japan Standard Stroke Registry Study (2015) Cardioembolic stroke is the most serious problem in the aging society. J Stroke Cerebrovasc Dis 24(4):811–814CrossRef Kato Y, Hayashi T, Tanahashi N, Kobayashi S, Japan Standard Stroke Registry Study (2015) Cardioembolic stroke is the most serious problem in the aging society. J Stroke Cerebrovasc Dis 24(4):811–814CrossRef
13.
Zurück zum Zitat Maeda K, Toyoda K, Minematsu K, Kobayashi S, The Japan Standard Stroke Registry Study (2013) Effects of sex difference on clinical features of acute ischemic stroke in Japan. J Stroke Cerebrovasc Dis 22(7):1070–1075CrossRef Maeda K, Toyoda K, Minematsu K, Kobayashi S, The Japan Standard Stroke Registry Study (2013) Effects of sex difference on clinical features of acute ischemic stroke in Japan. J Stroke Cerebrovasc Dis 22(7):1070–1075CrossRef
14.
Zurück zum Zitat Gordon DL, Bendixen BH, Adams HP Jr, Clarke W, Kappelle LJ, Woolson RF (1993) Interphysician agreement in the diagnosis of subtypes of acute ischemic stroke: implications for clinical trials. The TOAST investigators. Neurology 43(5):1021–1027CrossRef Gordon DL, Bendixen BH, Adams HP Jr, Clarke W, Kappelle LJ, Woolson RF (1993) Interphysician agreement in the diagnosis of subtypes of acute ischemic stroke: implications for clinical trials. The TOAST investigators. Neurology 43(5):1021–1027CrossRef
15.
Zurück zum Zitat Sacco RL, Kasner SE, Broderick JP et al (2013) An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 44(7):2064–2089CrossRef Sacco RL, Kasner SE, Broderick JP et al (2013) An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 44(7):2064–2089CrossRef
16.
Zurück zum Zitat Naccarelli GV, Varker H, Lin J, Schulman KL (2009) Increasing prevalance of atrial fibrillation and flutter in the United States. Am J Cardiol 104(11):1534–1539CrossRef Naccarelli GV, Varker H, Lin J, Schulman KL (2009) Increasing prevalance of atrial fibrillation and flutter in the United States. Am J Cardiol 104(11):1534–1539CrossRef
17.
Zurück zum Zitat Fang MC, Singer DE, Chang Y et al (2005) Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and risk factors in atrial fibrillation (ATRIA) study. Circulation 112(12):1687–1691CrossRef Fang MC, Singer DE, Chang Y et al (2005) Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and risk factors in atrial fibrillation (ATRIA) study. Circulation 112(12):1687–1691CrossRef
18.
Zurück zum Zitat Feinberg WM (1998) Anticoagulation for prevention of stroke. Neurology 51(3 Suppl 3):S20–S22CrossRef Feinberg WM (1998) Anticoagulation for prevention of stroke. Neurology 51(3 Suppl 3):S20–S22CrossRef
19.
Zurück zum Zitat Olesen JB, Lip GY, Hansen ML et al (2011) Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study. BMJ 342:d124CrossRef Olesen JB, Lip GY, Hansen ML et al (2011) Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study. BMJ 342:d124CrossRef
20.
Zurück zum Zitat Thijs VN, Brachmann J, Morillo CA et al (2016) Predictors for atrial fibrillation detection after cryptogenic stroke: results from CRYSTAL AF. Neurology 86(3):261–269CrossRef Thijs VN, Brachmann J, Morillo CA et al (2016) Predictors for atrial fibrillation detection after cryptogenic stroke: results from CRYSTAL AF. Neurology 86(3):261–269CrossRef
21.
Zurück zum Zitat Choe WC, Passman RS, Brachmann J et al (2015) A comparison of atrial fibrillation monitoring strategies after cryptogenic stroke (from the cryptogenic stroke and underlying AF trial). Am J Cardiol 116(6):889–893CrossRef Choe WC, Passman RS, Brachmann J et al (2015) A comparison of atrial fibrillation monitoring strategies after cryptogenic stroke (from the cryptogenic stroke and underlying AF trial). Am J Cardiol 116(6):889–893CrossRef
22.
Zurück zum Zitat Reiffel J, Verma A, Halperin JL et al (2014) Rationale and design of REVEAL AF: a prospective study of previously undiagnosed atrial fibrillation as documented by an insertable cardiac monitor in high-risk patients. Am J Cardiol 167(1):22–27 Reiffel J, Verma A, Halperin JL et al (2014) Rationale and design of REVEAL AF: a prospective study of previously undiagnosed atrial fibrillation as documented by an insertable cardiac monitor in high-risk patients. Am J Cardiol 167(1):22–27
23.
Zurück zum Zitat Reiffel JA, Verma A, Kowey PR et al (2017) Incidence of previously undiagnosed atrial fibrillation using insertable cardiac monitors in a high-risk population. The REVEAL AF study. JAMA Cardiol 2(10):1120–1127CrossRef Reiffel JA, Verma A, Kowey PR et al (2017) Incidence of previously undiagnosed atrial fibrillation using insertable cardiac monitors in a high-risk population. The REVEAL AF study. JAMA Cardiol 2(10):1120–1127CrossRef
24.
Zurück zum Zitat Minami M, Kobayashi Y, Toyokawa S, Inoue K, Takeshita Y (2009) Risk factors for new-onset atrial fibrillation during routine medical checkups of Japanese male workers. Int Heart J 50(4):457–464CrossRef Minami M, Kobayashi Y, Toyokawa S, Inoue K, Takeshita Y (2009) Risk factors for new-onset atrial fibrillation during routine medical checkups of Japanese male workers. Int Heart J 50(4):457–464CrossRef
25.
Zurück zum Zitat Go AS, Hylek EM, Chang YC et al (2003) Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice? JAMA 290(20):2685–2692CrossRef Go AS, Hylek EM, Chang YC et al (2003) Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice? JAMA 290(20):2685–2692CrossRef
26.
Zurück zum Zitat Gorelick PB, Sacco RL, Smith DB et al (1999) Prevention of a first stroke—a review of guidelines and a multidisciplinary consensus statement from the National Stroke Association. JAMA 281(1):1112–1120CrossRef Gorelick PB, Sacco RL, Smith DB et al (1999) Prevention of a first stroke—a review of guidelines and a multidisciplinary consensus statement from the National Stroke Association. JAMA 281(1):1112–1120CrossRef
27.
Zurück zum Zitat Nakayama H, Minematsu K, Yamaguchi T et al (2019) Approval of stroke and cardiovascular disease control act in Japan: comprehensive nationwide approach for prevention, treatment, and patients’ support. Int J Stroke 15(1):7–8CrossRef Nakayama H, Minematsu K, Yamaguchi T et al (2019) Approval of stroke and cardiovascular disease control act in Japan: comprehensive nationwide approach for prevention, treatment, and patients’ support. Int J Stroke 15(1):7–8CrossRef
Metadaten
Titel
Characteristics of aged ischemic stroke patients indicative of cardioembolism
verfasst von
Kosuke Matsuzono
Takafumi Mashiko
Tadashi Ozawa
Kumiko Miura
Masayuki Suzuki
Kohei Furuya
Misato Ozawa
Yuhei Anan
Haruo Shimazaki
Reiji Koide
Ryota Tanaka
Tomoaki Kameda
Shigeru Fujimoto
Publikationsdatum
24.06.2020
Verlag
Springer US
Erschienen in
Journal of Thrombosis and Thrombolysis / Ausgabe 2/2021
Print ISSN: 0929-5305
Elektronische ISSN: 1573-742X
DOI
https://doi.org/10.1007/s11239-020-02198-1

Weitere Artikel der Ausgabe 2/2021

Journal of Thrombosis and Thrombolysis 2/2021 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.